Ester Blanco

924 total citations
31 papers, 611 citations indexed

About

Ester Blanco is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ester Blanco has authored 31 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Ester Blanco's work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (8 papers). Ester Blanco is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (8 papers). Ester Blanco collaborates with scholars based in Spain, Italy and United Kingdom. Ester Blanco's co-authors include Grazyna Kochan, David Escors, Ana Bocanegra, Luisa Chocarro, Hugo Arasanz, Miriam Echaide, Ruth Vera, Leticia Fernández, Maider Garnica and Pablo Ramos and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Ester Blanco

30 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Blanco Spain 12 398 302 115 78 59 31 611
Luisa Chocarro Spain 14 504 1.3× 362 1.2× 134 1.2× 111 1.4× 61 1.0× 35 742
Miriam Echaide Spain 11 296 0.7× 239 0.8× 90 0.8× 54 0.7× 59 1.0× 24 474
Wilhem Leconet France 11 232 0.6× 178 0.6× 141 1.2× 62 0.8× 78 1.3× 12 514
Dikan Wang China 9 218 0.5× 182 0.6× 111 1.0× 54 0.7× 77 1.3× 17 477
Michael Fehlings Singapore 10 370 0.9× 442 1.5× 217 1.9× 59 0.8× 134 2.3× 21 756
Margherita Passariello Italy 14 305 0.8× 165 0.5× 219 1.9× 40 0.5× 56 0.9× 32 589
Emily F. Higgs United States 7 336 0.8× 421 1.4× 207 1.8× 52 0.7× 72 1.2× 15 619
Aditi Kothari United States 5 346 0.9× 258 0.9× 237 2.1× 58 0.7× 44 0.7× 10 523
Kenzo Ohara Japan 12 274 0.7× 406 1.3× 167 1.5× 36 0.5× 65 1.1× 36 553
Douglas E. Kline United States 11 228 0.6× 511 1.7× 165 1.4× 39 0.5× 46 0.8× 15 664

Countries citing papers authored by Ester Blanco

Since Specialization
Citations

This map shows the geographic impact of Ester Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Blanco more than expected).

Fields of papers citing papers by Ester Blanco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Blanco. The network helps show where Ester Blanco may publish in the future.

Co-authorship network of co-authors of Ester Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Blanco. A scholar is included among the top collaborators of Ester Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Blanco. Ester Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2024). PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Molecular Medicine. 16(8). 1791–1816. 11 indexed citations
2.
Blanco, Ester, Ana Bocanegra, Luisa Chocarro, et al.. (2024). Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British Journal of Cancer. 130(5). 869–879. 9 indexed citations
3.
Blanco, Ester, Luisa Chocarro, Leticia Fernández, et al.. (2023). Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International Journal of Molecular Sciences. 24(3). 2676–2676. 11 indexed citations
4.
Arasanz, Hugo, Luisa Chocarro, Leticia Fernández, et al.. (2023). Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International Journal of Molecular Sciences. 24(12). 9855–9855. 6 indexed citations
5.
Blanco, Ester, Teresa Lozano, Eva Martišová, et al.. (2023). Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses. Cancer Letters. 561. 216139–216139. 13 indexed citations
6.
Echaide, Miriam, Luisa Chocarro, Ana Bocanegra, et al.. (2023). mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. International Journal of Molecular Sciences. 24(6). 5944–5944. 48 indexed citations
7.
Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Cardiovascular Diseases. 12448–12448. 1 indexed citations
8.
Garnica, Maider, Anna Aiello, Mattia Emanuela Ligotti, et al.. (2022). How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. International Journal of Molecular Sciences. 23(17). 9797–9797. 11 indexed citations
9.
Chocarro, Luisa, Hugo Arasanz, Leticia Fernández, et al.. (2022). CAR-T Cells for the Treatment of Lung Cancer. Life. 12(4). 561–561. 14 indexed citations
10.
Arasanz, Hugo, Ana Bocanegra, Idoia Morilla, et al.. (2022). Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 14(16). 3846–3846. 26 indexed citations
11.
Escors, David, Ana Bocanegra, Luisa Chocarro, et al.. (2022). Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. International Journal of Molecular Sciences. 23(21). 13241–13241. 11 indexed citations
12.
Aiello, Anna, Mattia Emanuela Ligotti, Maider Garnica, et al.. (2022). How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International Journal of Molecular Sciences. 23(17). 9880–9880. 16 indexed citations
13.
Echaide, Miriam, Ibone Labiano, Ángela Fernández de Lascoiti, et al.. (2022). Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers. 14(18). 4464–4464. 9 indexed citations
14.
Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Inflammatory Diseases. 12447–12447. 1 indexed citations
15.
Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). Clinical landscape of LAG-3-targeted therapy. Immuno-Oncology Technology. 14. 100079–100079. 71 indexed citations
16.
Lachén‐Montes, Mercedes, Karina Ausín, Miriam Echaide, et al.. (2022). Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions. Frontiers in Immunology. 13. 866564–866564.
17.
Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). LAG-3 Role in Neurological Diseases. 12449–12449. 1 indexed citations
18.
Chocarro, Luisa, Ester Blanco, Hugo Arasanz, et al.. (2022). Role of the next-generation immune checkpoint LAG-3 in response and resistance to cancer immunotherapy. 12446–12446. 1 indexed citations
19.
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 22(7). 3736–3736. 20 indexed citations
20.
Hernández, Carlos, Hugo Arasanz, Luisa Chocarro, et al.. (2020). Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International Journal of Molecular Sciences. 21(7). 2411–2411. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Chocarro Breakdown of academic impact, for papers by Miriam Echaide Breakdown of academic impact, for papers by Wilhem Leconet Breakdown of academic impact, for papers by Dikan Wang Breakdown of academic impact, for papers by Michael Fehlings Breakdown of academic impact, for papers by Margherita Passariello Breakdown of academic impact, for papers by Emily F. Higgs Breakdown of academic impact, for papers by Aditi Kothari Breakdown of academic impact, for papers by Kenzo Ohara Breakdown of academic impact, for papers by Douglas E. Kline
Rankless by CCL
2026